Literature DB >> 4171046

Effect of ageing of serum on consumption of antibody by beta-1C-globulin determinants; evidence for circulating breakdown products in glomerulonephritis.

C D West, S Winter, J Forristal, N C Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 4171046      PMCID： PMC1578903     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  10 in total

1.  SERUM LEVELS OF BETA-1C GLOBULIN, A COMPLEMENT COMPONENT, IN THE NEPHRITIDES, LIPOID NEPHROSIS, AND OTHER CONDITIONS.

Authors:  C D WEST; J D NORTHWAY; N C DAVIS
Journal:  J Clin Invest       Date:  1964-08       Impact factor: 14.808

2.  QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES.

Authors:  J L FAHEY; E M MCKELVEY
Journal:  J Immunol       Date:  1965-01       Impact factor: 5.422

3.  Estimation of eight serum proteins by a gel diffusion precipitin technique.

Authors:  J F SOOTHILL
Journal:  J Lab Clin Med       Date:  1962-05

4.  Quantitative determination of the serum globulins beta-2A and beta-2M by immunoelectrophoretic analysis.

Authors:  C D WEST; V HINRICHS; N H HINKLE
Journal:  J Lab Clin Med       Date:  1961-07

5.  Anti-nuclear factors and serum complement in systemic lupus erythematosus.

Authors:  J H MORSE; H J MULLER-EBERHARD; H G KUNKEL
Journal:  Bull N Y Acad Med       Date:  1962-10

6.  Altered complement component C3A (beta-1C--beta-1A) in patients with glomerulonephritis.

Authors:  J F Soothill
Journal:  Clin Exp Immunol       Date:  1967-01       Impact factor: 4.330

7.  Antigenic determinants of human beta-1c and beta-1g-globulins.

Authors:  C West; N C Davis; J Forristal; J Herbst; R Spitzer
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

8.  Evidence for in vivo breakdown of beta-10-globulin in hypocomplementemic glomerulonephritis.

Authors:  C D West; S Winter; J Forristal; J M McConville; N C Davis
Journal:  J Clin Invest       Date:  1967-04       Impact factor: 14.808

9.  Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.

Authors:  H J Müller-Eberhard; M J Polley; M A Calcott
Journal:  J Exp Med       Date:  1967-02-01       Impact factor: 14.307

10.  The reaction mechanism of beta-1C-globulin (C'3) in immune hemolysis.

Authors:  H J Müllerèberhard; A P Dalmasso; M A Calcott
Journal:  J Exp Med       Date:  1966-01-01       Impact factor: 14.307
  10 in total
  6 in total

1.  Studies of the third component of complement in synovial fluid from arthritic patients. II. Conversion and its relation to total complement.

Authors:  H Hedberg; B Lundh; A B Laurell
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

2.  Interaction of complex polysaccharides with the complement system: effect of calcium depletion on terminal component consumption.

Authors:  R Snyderman; M C Pike
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

3.  Comparison of a fluorometric method with radial immunodiffusion assays for determination of complement components C3 and C4.

Authors:  M Koelle; W R Bartholomew
Journal:  J Clin Microbiol       Date:  1982-08       Impact factor: 5.948

4.  Hypocomplementemia of membranoproliferative nephritis. Dependence of the nephritic factor reaction on properdin factor B.

Authors:  E J Ruley; J Forristal; N C Davis; C Andres; C D West
Journal:  J Clin Invest       Date:  1973-04       Impact factor: 14.808

5.  Requirements for beta1H globulin and C3b inactivator in the control of the alternative complement pathway in human serum.

Authors:  K Whaley; R A Thompson
Journal:  Immunology       Date:  1978-12       Impact factor: 7.397

6.  In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia.

Authors:  L D Petz; D J Fink; E A Letsky; H H Fudenberg; J Müller-Eberhard
Journal:  J Clin Invest       Date:  1969-11       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.